Prognostic score of gastric cancer determined by cDNA microarray

Clinical Cancer Research

Volumn 8, Issue 11, 2002, Pages 3475-3479

  Inoue, Hiroshi ^a   Matsuyama, Ayumi ^a   Mimori, Koshi ^a   Ueo, Hiroaki ^a   Mori, Masaki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RNA ANALYSIS; STOMACH CANCER; GENETICS; METABOLISM; METASTASIS; NORTHERN BLOTTING; NUCLEIC ACID HYBRIDIZATION; STATISTICS; STOMACH TUMOR;

COMPLEMENTARY DNA;

BLOTTING, NORTHERN; DNA, COMPLEMENTARY; HUMANS; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; STATISTICS; STOMACH NEOPLASMS;

EID: 0036850147     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Akoh, J. A., and Macintyre, I. M. C. Improving survival in gastric cancer-review of 5-year survival rates in English language publications from 1970. Br. J. Surg., 79: 293-299, 1992.
2. Stadtlander, C. T. K. H., and Waterbor, J. W. Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis (Lond.), 20: 2195-2207, 1999.
3. Mori, M., Mimori, K., Shiraishi, T., Fujie, T., Baba, K., Kusumoto, H., Haraguchi, M., Ueo, H., and Akiyoshi, T. Analysis of MT1-MMP and MMP2 expression in human gastric cancers. Int. J. Cancer, 74: 316-321, 1997.
4. Mori, M., Mimori, K., Shiraishi, T., Tanaka, S., Ueo, H., Sugimachi, K., and Akiyoshi, T. p27 expression and gastric carcinoma. Nat. Med., 3: 593-593, 1997.
5. Mori, M., Kakeji, Y., Adachi, Y., Moriguchi, S., Maehara, Y., Sugimachi, K., Jessup, J. M., Chen, L. B., and Steele, G. D. The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer. Surgery, 113: 683-690, 1993.
6. Allgayer, H., Heiss, M. M., and Schildberg, F. W. Prognostic factors in gastric cancer. Br. J. Surg., 84: 1651-1664, 1997.
7. Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., Bloomfield, C. D., and Lander, E. S. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science (Wash. DC), 286: 531-537, 1999.
8. Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., Powell, J. I., Yang, L., Marti, G. E., Moore, T., Hudson, J., Jr., Lu, L., Lewis, D. B., Tibshirani, R., Sherlock, G., Chan, W. C., Greiner, T. C., Weisenburger, D. D., Armitage, J. O., Warnke, R., Staudt, L. M., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (Lond.), 403: 503-511, 2000.
9. Okabe, H., Satoh, S., Kato, T., Kitahara, O., Yanagawa, R., Yamaoka, Y., Tsunoda, T., Furukawa, Y., and Nakamura, Y. Genomewide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: Identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res., 61: 2129-2137, 2000.
10. Mori, M., Barnard, G. F., Staniunas, R. J., Jessup, J. M., Steele, G. D., and Chen, L. B. Prothymosin-α mRNA expression correlates with that of c-myc in human colon cancer. Oncogene, 8: 2821-2826, 1993.
11. Mori, M., and Sugimachi, K. Clinicopathologic studies of gastric carcinoma. Semin. Surg. Oncol., 6: 19-27, 1990.
12. Chang, Y. C., Nagasue, N., Abe, S., Kohno, H., Kumar, D. D., and Nakamura, T. α-fetoprotein producing early gastric cancer with liver metastasis-report of 3 cases. Gut, 32: 542-545, 1991.
13. Honda, M., Mori, M., Ueo, H., Sugimachi, K., and Akiyoshi, T. Matrix metalloproteinase-7 expression in gastric carcinoma. Gut, 39: 444-448, 1996.
14. Thomas, R., True, L. D., Bassuk, J. A., Lange, P. H., and Vessella, R. L. Differential expression of osteonectin/SPARC during human prostate cancer progression. Clin. Cancer Res., 6: 1140-1149, 2000.
15. Li, C. G., Wang, J. M., Wilson, P. B., Kumar, P., Levine, E., Hunter, R. D., and Kumar, S. Role of transforming growth factor β3 in lymphatic metastasis in breast cancer. Int. J. Cancer, 79: 455-459, 1998.
16. Mori, M., Barnard, G. F., Mimori, K., Ueo, H., Akiyoshi, T., and Sugimachi, K. Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas. Cancer (Phila.), 75: 1516-1519, 1995.
17. Yamashita, K., Mori, M., Shiraishi, T., Shibuta, K., and Sugimachi, K. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma. Clin. Cancer Res., 6: 1169-1174, 2000.
18. Tokunaga, T., Nakamura, M., Oshika, Y. Abe, Y., Ozeki, Y., Fukushima, Y., Hatanaka, H., Sadahiro, S., Kijima, H., Tsuchida, T., Yamazaki, H., Tamaoki, N., and Ueyama, Y. Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer. Br. J. Cancer, 79: 354-359, 1999.
19. Oshika, Y., Masuda, K., Tokunaga, T., Hatanaka, H., Kamiya, T., Abe, Y., Ozeki, Y., Kijima, H., Yamazaki, H., Tamaoki, N., Ueyama, Y., and Nakamura, M. Thrombospondin 2 gene expression is correlated with decreased vascularity in non-small cell lung cancer. Clin. Cancer Res., 4: 1785-1788, 1998.
20. Lee, J. H., Koh, J. T., Shin, B. A., Ahn, K. Y., Roh, J. H., Kim, Y. J., and Kim, K. K. Comparative study of angiostatic and anti-invasive gene expressions as prognostic factors in gastric cancer. Int. J. Oncol., 18: 355-361, 2001.